Nanocarriers for Nucleic Acids and Proteins

Luis H. Reyes, PhD, is an associate professor at Universidad de Los Andes (Bogotá, Colombia), where he leads research at the intersection of biological engineering and therapeutic delivery systems. He holds a BS in Chemical Engineering from Universidad Industrial de Santander (Colombia) and a PhD in Chemical Engineering from Texas A&M University.Juan C. Cruz, PhD, is a distinguished researcher and engineer at the Department of Biomedical Engineering, Universidad de Los Andes (Bogotá, Colombia), where he has been advancing the frontiers of nanobiotechnology since 2016. He holds a BS in Chemical Engineering from the National University of Colombia and earned his PhD in Chemical Engineering from Kansas State University, where his innovative work established a new platform for enzyme immobilization for applicstions in non-aqueous media.Yashwant V. Pathak received his PhD from Nagpur University, India, Executive MBA and Masters in Conflict Management, Sullivan University, Louisville, KY, USA. He has over 45 years’ experience in Academia and Industry. Presently, he is Professor and Associate Dean for Faculty Affairs at Taneja College of Pharmacy, University of South Florida, Tampa, FL, USA. Yashwant has published over 400 research papers, reviews and chapters with close to 5000 citations in Google Scholar. He edited over 70 books in nanotechnology, nutraceuticals, drug delivery systems, artificial intelligence, and artificial neural network. He has keen interest in conflict management and edited several books in the areas of organizational conflict management, handbook of organizational conflict management, Eastern and Indigenous perspectives in conflict management, RSS way of resolving conflicts and these two volumes on nonprofit organizations’ conflict management.

• Chapter 1: Introduction to Nanocarriers for Nucleic Acids and Proteins. Juan C. Cruz, Yashwant V Pathak and Luis H. ReyesChapter 2: Design Principles of Nanocarriers: Size, Shape, and Surface Properties, Stimuli-Responsive Systems.Juan C. Cruz, Luis H. ReyesChapter 3: Lipid-Based Nano Carriers for Nucleic Acids and Proteins: Liposomes, solid lipid nanoparticles, nanostructured lipid carriersBiswajit Basu, Ayon Dutta, Dipanjana Ash, Bhupendra Prajapati*, Swarupananda MukherjeeChapter 4: Polymer-based nanocarriers: dendrimers, polymeric micelles, hydrogelsJuan C. Cruz and Luis H. ReyesChapter 5: Inorganic nano carriers: gold nanoparticles, iron nanoparticles, silica nanoparticles, quantum dotsJuan C. Cruz,and Luis H. ReyesChapter 6: Carbon-based nano carriers: Carbon nanotubes, graphene oxide, fullerenes, and Carbon dotsCristian F. Rodríguez, Paula Guzmán-Sastoque, Coryna Rodriguez-Bazurto, Juan C. Rojas-Hernández, Luis H. Reyes, Juan C. Cruz Chapter 7 : Virus Inspired Nano CarriersAnkita Alice Singh, Seema KohliChapter 8: Nucleic acid nano carriers DNA nanostructures, RNA nanostructures, hybrid nucleic acid systemsKomal Parmar, and Jayvadan PatelChapter 9 : Protein-based nano carriers: protein cages, self-assembling peptides, fusion proteins,Nishant B. Chopade, Prashant K. Deshmukh,and Mahesh P. MoreChapter 10 : Nanocarrier Functionalization Strategies: Targeting Ligands, Imaging Agents, stimuli-responsive ElementsSampada Satish Shinde, Bhavna Sonule, Lalit KumarChapter 11: Delivery of nucleic acids using nano carriers: siRNA and miRNA delivery, mRNA and DNA delivery, CRISPR-Cas systemsPaula Guzmán–Sastoque,María Camila Monsalve, Cristian F. Rodríguez, Stiven Castellanos,Juan C. Cruz, and Luis H. ReyesChapter 12: Delivery of proteins using nanocarriers: enzymes, antibodies and growth factorsJennifer Suurbaar,Frederick Sarfo-Antwi Seth Kwabena Amponsah,Chapter 13 : Nanocarrier in gene therapySinjini Sarkar, Swarupananda Mukherjee, Shilpa Chatterjee, Biswajit Basu, Dipanjan Karati, Bhupendra PrajapatiChapter 14: Nanocarriers in Cancer Immunotherapy: Personalized Cancer Vaccines, Immune Checkpoint Modulation,Adoptive T-Cell TherapyVineet Mahajan and Yashwant PathakChapter 15: Future perspectives and challenges: clinical translation and regulatory aspects, scale-up andmanufacturing, ethical considerationsAparoop Das, Kalyani Pathak Riya Saikia, Manash Pratim Pathak,Urvashee Gogoi, Dibyajyoti Das, Jon Jyoti Sahariah, Saptasikha Gogoi and Sukanya SonowaChapter 16: Regulatory Toxicology of Biologics: Safeguarding Health in Biotherapeutic DevelopmentSatish Rojekar, Nishant Talati, Shahin Vhora, Nidhi Kotadiya, Mitul Talala, Ruby Chrisitan, Vikas Jain, Tosha Pandya, Disha Suthar, and Kinjal Parikh